Testing effectiveness (Phase 2)UnknownNCT05290337What this trial is testingZR-CHOP in DLBCL With Specific Gene AbnormalityWho this might be right forDiffuse Large B Cell Lymphoma Fudan University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06760039What this trial is testingSafety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCLWho this might be right forDiffuse Large B-Cell Lymphoma Sun Yat-sen University 112
Large-scale testing (Phase 3)Looking for participantsNCT04442412What this trial is testingPrephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by ImmunochemotherapyWho this might be right forDiffuse Large B-Cell LymphomaElderly Patients Fondazione Italiana Linfomi - ETS 430
Not applicableNot Yet RecruitingNCT07198373What this trial is testingExploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell LymphomaWho this might be right forB Cell Lymphoma Beijing GoBroad Hospital 40
Not applicableLooking for participantsNCT06508775What this trial is testingLong-Term Follow-up of Patients Treated With Miltenyi Cell and Gene TherapiesWho this might be right forMelanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more Miltenyi Biomedicine GmbH 40
Large-scale testing (Phase 3)UnknownNCT02531841What this trial is testingHigh-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS LymphomaWho this might be right forDiffuse Large B-cell-lymphoma University Hospital Freiburg 250
Very early researchLooking for participantsNCT07048353What this trial is testingCD30 CAR-T in the Treatment of CD30 Positive LymphomaWho this might be right forLymphomaB Cell LymphomaCD30+ Peripheral T-cell Lymphoma Shandong Qilu Cell Therapy Engineering Technology Co., Ltd 15
Testing effectiveness (Phase 2)Study completedNCT02077166What this trial is testingIbrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma Pharmacyclics LLC. 138
Testing effectiveness (Phase 2)Ended earlyNCT00112723What this trial is testingFlavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 46
Not applicableStudy completedNCT00476229What this trial is testingThymoglobulin and Total Lymphoid Irradiation for Hematologic MalignanciesWho this might be right forLymphomaLeukemia M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729What this trial is testingA Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06687772What this trial is testingCNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell TransplantWho this might be right forDiffuse Large B Cell Lymphoma Washington University School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07519772What this trial is testingA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)Who this might be right forLymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse Merck Sharp & Dohme LLC 280
Testing effectiveness (Phase 2)UnknownNCT02060656What this trial is testingPhase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Who this might be right forDiffuse Large B-Cell Lymphoma Royal Marsden NHS Foundation Trust 92
Testing effectiveness (Phase 2)WithdrawnNCT01854372What this trial is testingRituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.Who this might be right forNewly Diagnosed Diffuse Large B-Cell LymphomaIntermediate (Burkitt-Like) Lymphoma The University of Texas Health Science Center at San Antonio
Very early researchWithdrawnNCT05015972What this trial is testingUCAR-T for CD19+ Refractory/Relapsed B Hematologic MalignanciesWho this might be right forB-cell Lymphoma 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Large-scale testing (Phase 3)Looking for participantsNCT05820841What this trial is testingAcalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell LymphomaWho this might be right forLarge B-cell LymphomaDiffuse Large B Cell Lymphoma Universität des Saarlandes 330
Testing effectiveness (Phase 2)Looking for participantsNCT05092451What this trial is testingPhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesWho this might be right forB-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more M.D. Anderson Cancer Center 80
Large-scale testing (Phase 3)Looking for participantsNCT06943872What this trial is testingInvestigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Who this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeOne Medicines 630
Testing effectiveness (Phase 2)Study completedNCT00055653What this trial is testingDonor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Roswell Park Cancer Institute